159 related articles for article (PubMed ID: 23946770)
1. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma.
Huang JX; Zhao K; Lin M; Wang Q; Xiao W; Lin MS; Yu H; Chen P; Qian RY
Oncol Lett; 2013 Jul; 6(1):13-18. PubMed ID: 23946770
[TBL] [Abstract][Full Text] [Related]
2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
3. Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma.
Muhetaer A; Niyaz M; Ainiwaer J; Liwei Z; Awut E
Mol Clin Oncol; 2020 Nov; 13(5):64. PubMed ID: 32968485
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry.
Sato-Kuwabara Y; Neves JI; Fregnani JH; Sallum RA; Soares FA
BMC Cancer; 2009 Jan; 9():6. PubMed ID: 19128465
[TBL] [Abstract][Full Text] [Related]
5. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
[TBL] [Abstract][Full Text] [Related]
6. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
Kato H; Arao T; Matsumoto K; Fujita Y; Kimura H; Hayashi H; Nishiki K; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T; Okuno K; Shiozaki H; Nishio K
Int J Oncol; 2013 Apr; 42(4):1151-8. PubMed ID: 23426935
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.
Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM
Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592
[TBL] [Abstract][Full Text] [Related]
8. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.
Zhan N; Dong WG; Tang YF; Wang ZS; Xiong CL
Med Oncol; 2012 Jun; 29(2):933-40. PubMed ID: 21318736
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
[TBL] [Abstract][Full Text] [Related]
11. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR
Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138
[TBL] [Abstract][Full Text] [Related]
12. Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.
Guo K; Wang WP; Jiang T; Wang JZ; Chen Z; Li Y; Zhou YA; Li XF; Lu Q; Zhang LJ
J Thorac Dis; 2016 Jul; 8(7):1753-63. PubMed ID: 27499966
[TBL] [Abstract][Full Text] [Related]
13. Investigation of
Heidarpour M; Taheri M; Akhavan A; Goli P; Kefayat A
Iran J Pathol; 2020; 15(4):274-281. PubMed ID: 32944039
[TBL] [Abstract][Full Text] [Related]
14. Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas.
Gonzaga IM; Soares-Lima SC; de Santos PT; Blanco TC; de Reis BS; Quintella DC; de Oliveira IM; de Faria PA; Kruel CD; Andreollo NA; de Simão TA; Pinto LF
BMC Cancer; 2012 Dec; 12():569. PubMed ID: 23207070
[TBL] [Abstract][Full Text] [Related]
15. Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients.
Hadi AA; Hindawi AE; Hareedy A; Khalil H; Ashiry RA; Elia S; Sadek A; Magdy M; Atta R; Anas A; Bakr H; Hammam O
Open Access Maced J Med Sci; 2016 Dec; 4(4):535-542. PubMed ID: 28028387
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma.
Chen Y; Zhu SM; Xu XL; Zhao AN; Hu JL
Oncol Lett; 2016 Jan; 11(1):745-752. PubMed ID: 26870278
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
19. Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
Berezowska S; Novotny A; Bauer K; Feuchtinger A; Slotta-Huspenina J; Becker K; Langer R; Walch A
PLoS One; 2013; 8(7):e69098. PubMed ID: 23874879
[TBL] [Abstract][Full Text] [Related]
20. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus.
Pandeya N; Williams GM; Sadhegi S; Green AC; Webb PM; Whiteman DC
Am J Epidemiol; 2008 Jul; 168(1):105-14. PubMed ID: 18483122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
